By Daniel Akselrod · July 2026

Intake Forms for Dermatology Practices: Skin Concerns, Sun Exposure History, and Medication Documentation

A patient walks into a dermatology office and says she wants her moles checked. That sentence contains almost no actionable clinical information. Is she here because a mole changed shape last month, or because she read an article about melanoma and wants a routine screening? Has she had five blistering sunburns before age eighteen, or has she spent her entire adult life indoors? Is she taking a medication that makes her skin photosensitive, or is she on isotretinoin and considering a chemical peel that could cause severe scarring? The distance between a routine skin check and an urgent biopsy referral can be a single question on an intake form — and if that question is missing, the clinician starts the encounter blind.

Dermatology intake is unusual among medical specialties because the same practice often straddles two entirely different billing worlds. A patient who presents with acne may be seeking medical treatment covered by insurance, or she may be asking about cosmetic procedures she will pay for out of pocket. The intake form is the first point where that classification happens, and getting it wrong is not a minor clerical error — it is a billing mistake that can trigger insurance audits, claim denials, and revenue loss that compounds across hundreds of patient encounters per month. A purpose-built dermatology intake form captures the clinical, historical, and administrative data that drives every downstream decision in the practice.

Chief skin complaint: what the form must capture before the exam room door opens

The chief complaint section on a dermatology intake needs to go well beyond "rash" or "spot on arm." Skin complaints are visual and spatial, and the information a patient provides on paper before the examination determines how efficiently the dermatologist uses the face-to-face time that insurance reimburses in shrinking increments.

Location is the starting point. A lesion on the scalp has a different differential than the same-appearing lesion on the shin. A rash confined to sun-exposed areas suggests a photosensitivity reaction; the same rash in skin folds suggests a fungal or intertrigo process. The intake form should capture not just "where" but whether the condition affects one site or multiple sites, whether it is symmetric or asymmetric, and whether it has spread since onset. Duration matters just as much. A lesion present for ten years with no changes is a different clinical priority than the same lesion that appeared six weeks ago and has been growing. The form needs specific timeframes — weeks, months, years — not vague checkboxes for "recent" versus "long-standing."

Changes over time are the data points that separate a concerning lesion from a benign one. Has the spot changed color, size, shape, or texture? Has a previously flat lesion become raised? Has it started bleeding spontaneously, or does it bleed only with trauma? Has a mole developed irregular borders or multiple colors? These are the ABCDE melanoma warning signs translated into intake questions, and they need to be captured in writing before the patient enters the exam room so the dermatologist can prioritize the clinical exam accordingly. Associated symptoms round out the picture: itching suggests an inflammatory or allergic process, pain suggests infection or a neural component, and bleeding without trauma is a red flag that accelerates the biopsy conversation.

Sun exposure history: the section that drives skin cancer risk stratification

No other section on a dermatology intake form carries as much weight for long-term risk assessment as the sun exposure history. Cumulative ultraviolet exposure is the single largest modifiable risk factor for both melanoma and non-melanoma skin cancers, and a patient's lifetime sun history cannot be reconstructed from a physical exam alone. The skin shows some of the damage — solar lentigines, actinic keratoses, deep wrinkling — but it does not show whether a forty-year-old patient had three blistering sunburns at age twelve, used tanning beds twice a week through college, or spent a decade working construction without sunscreen.

Childhood and adolescent sun exposure is particularly critical. Research consistently shows that severe sunburns before age twenty carry a disproportionate melanoma risk that persists for decades. The intake form should ask specifically about childhood sunburns — not whether the patient "spent time in the sun as a child," which nearly everyone did, but whether they experienced blistering or peeling sunburns and approximately how many. Tanning bed use is the second major exposure category that must be documented explicitly. Indoor tanning before age thirty-five increases melanoma risk by seventy-five percent according to published epidemiological data, and many patients do not think to mention tanning bed use from fifteen years ago unless the form asks directly.

Occupational and recreational exposure rounds out the sun history. A patient who has worked as a lifeguard, landscaper, farmer, roofer, or commercial fisherman has a fundamentally different cumulative UV dose than a patient who has worked indoors for thirty years. The same applies to recreational patterns: a patient who sails, surfs, golfs, or runs marathons outdoors accumulates exposure that matters clinically. Finally, current sun protection habits — sunscreen use, SPF level, frequency of reapplication, hat and protective clothing use — tell the dermatologist whether the patient is actively managing their risk or whether patient education on photoprotection needs to be part of the visit. Together, these data points let the dermatologist assign a skin cancer risk tier at the very first visit and calibrate the surveillance schedule accordingly.

Medication history: the drugs that change what dermatologists can safely do

Every medical intake form asks about medications, but dermatology has a specific set of drug categories that directly affect treatment decisions in ways that other specialties do not face. The most consequential is isotretinoin. A patient who is currently taking isotretinoin, or who completed a course within the past six months, cannot undergo chemical peels, dermabrasion, laser resurfacing, or waxing without a significant risk of abnormal scarring and delayed wound healing. If the intake form does not capture isotretinoin history with specific dates, a practice could inadvertently perform a procedure that causes permanent scarring on a patient whose skin has not yet recovered its normal healing capacity.

Photosensitizing medications are the second critical drug category. Tetracyclines — including doxycycline, which dermatologists themselves frequently prescribe for acne and rosacea — increase the skin's sensitivity to ultraviolet light. So do thiazide diuretics, certain NSAIDs, fluoroquinolone antibiotics, amiodarone, and several psychiatric medications including certain antipsychotics. A patient on doxycycline who undergoes a phototherapy session or even extended sun exposure during a full-body skin exam can experience a phototoxic reaction. The intake form must capture these medications so the dermatologist can counsel on sun protection and adjust treatment plans involving UV exposure.

Immunosuppressants and biologics represent the third category with dermatology-specific implications. Patients on methotrexate, cyclosporine, mycophenolate, or biologic agents such as adalimumab, etanercept, or ustekinumab have altered immune surveillance that increases their risk of both skin infections and skin cancers. These patients require more frequent skin cancer screenings, and their wound healing and infection risk profiles change the calculus for any procedural intervention. Anticoagulants matter for procedural planning — a patient on warfarin, rivaroxaban, or apixaban who needs a biopsy or excision requires modified hemostasis protocols, and the intake form is where that planning begins.

Family history of skin conditions: hereditary risks the patient cannot see

Skin cancer risk is not determined solely by sun exposure. A patient with a first-degree relative who had melanoma carries roughly double the baseline melanoma risk, and patients with two or more affected first-degree relatives are in a risk category that may warrant genetic counseling and referral for CDKN2A or other germline mutation testing. The dermatology intake form must ask about family history of melanoma specifically — not just "cancer" in a general sense, because a family history of breast or colon cancer, while important for the primary care record, does not change the dermatology surveillance plan the way a family history of melanoma does.

Beyond melanoma, the form should capture family history of non-melanoma skin cancers, particularly basal cell carcinoma and squamous cell carcinoma, because a strong family pattern suggests possible genetic susceptibility syndromes such as Gorlin syndrome or xeroderma pigmentosum. Inflammatory skin conditions with genetic components also belong on the form: psoriasis, eczema and atopic dermatitis, vitiligo, alopecia areata, and hidradenitis suppurativa all run in families, and a positive family history changes both the probability of certain diagnoses and the counseling the dermatologist provides about disease course and management expectations. A patient presenting with a scaly elbow patch who also reports that her mother and sister both have psoriasis is a very different clinical picture from the same patch on a patient with no family history — and that distinction should be documented before the exam, not discovered during it.

Cosmetic versus medical visit classification: the intake decision that determines who pays

This is the section of the dermatology intake that has the most direct financial impact on the practice, and it is the one most frequently handled poorly. Dermatology is one of a small number of medical specialties where a single practice routinely performs both insurance-billed medical procedures and patient-pay cosmetic procedures, sometimes on the same patient in the same visit. The classification of a visit as medical or cosmetic determines whether the practice bills an insurance carrier or collects directly from the patient, and that classification must be documented at intake — not decided retroactively when the billing department processes the encounter.

The distinction seems simple in principle: if a condition is medically necessary to diagnose or treat, it is a medical visit billed to insurance. If the patient is seeking an elective improvement in appearance with no underlying medical pathology, it is cosmetic and patient-pay. In practice, the line blurs constantly. Acne scarring can be cosmetic or medical depending on severity and functional impact. A suspicious mole removal is medical; removal of a benign mole the patient finds unattractive is cosmetic. Botox for wrinkles is cosmetic; Botox for chronic migraine or hyperhidrosis is medical. Laser treatment for sun damage can fall on either side depending on whether actinic keratoses are present.

The intake form is the first and best place to establish this classification. It should capture the patient's stated reason for the visit in their own words, ask directly whether the concern is medical or cosmetic in nature, and include a section where the practice documents its classification determination. When a visit involves both medical and cosmetic components — a patient who wants a skin cancer screening and also wants to discuss Botox — the form should capture both so the billing is split correctly. A practice that misclassifies a cosmetic procedure as medical risks insurance fraud allegations. A practice that misclassifies a medical procedure as cosmetic leaves insurance reimbursement on the table. Across hundreds of patient encounters per month, classification errors compound into thousands of dollars in lost revenue or compliance exposure.

Previous dermatologic treatments: the procedural history that shapes what comes next

A patient's history of prior dermatologic treatments is not background information — it is clinical data that directly constrains the current treatment plan. A patient who has had a lesion biopsied previously needs the biopsy results documented: was it benign, dysplastic, malignant, or inadequately sampled? A prior diagnosis of dysplastic nevi changes the surveillance protocol for every subsequent skin exam. A prior melanoma diagnosis, even if successfully treated, places the patient in a high-risk surveillance category for life.

Procedural history matters for treatment planning in ways that extend beyond cancer. A patient who has undergone Mohs micrographic surgery has a scar with specific tissue characteristics that affect future procedures in the same area. A patient with a history of keloid or hypertrophic scarring after excision needs modified closure techniques or may be a candidate for alternative treatment modalities entirely. Prior laser treatments — type of laser, treated area, number of sessions, and any adverse reactions — inform whether additional laser work is appropriate and which parameters to use. Cryotherapy history tells the dermatologist whether a patient tolerates the procedure well and whether prior cryotherapy in the same area produced satisfactory cosmetic results or left hypopigmented scars that the patient found unacceptable.

The intake form should also capture topical treatment history: which prescription topicals the patient has used previously, for how long, and whether they were effective. A patient who has already failed multiple topical retinoids and topical antibiotics for acne is a different treatment conversation than a patient presenting with acne for the first time. A patient who has used topical corticosteroids on her face for months may have steroid-induced rosacea or skin atrophy that looks like a primary dermatologic condition but is actually iatrogenic. Without a structured medication and treatment history captured at intake, the dermatologist risks repeating failed treatments or missing drug-induced skin changes.

Allergies and sensitivities: the reactions that change the treatment toolkit

Dermatology-specific allergy documentation goes beyond the standard medication allergy list. Latex allergy affects glove selection during every procedural encounter. Adhesive allergy matters for wound dressings after biopsies and excisions. Nickel allergy is relevant for patients with contact dermatitis whose exposure source may be jewelry, belt buckles, or even surgical implant components. Fragrance and preservative sensitivities affect which topical medications, cleansers, and moisturizers the dermatologist can recommend — a patient with a documented methylisothiazolinone sensitivity cannot use half the over-the-counter products on a pharmacy shelf, and the dermatologist needs to know that before writing a skin care regimen.

Local anesthetic allergy, while rare, is critical for procedural planning. A patient who reports a prior reaction to lidocaine needs a documented assessment of whether the reaction was a true allergy, a vasovagal response, or a reaction to the epinephrine component. This determination changes whether the practice uses an alternative anesthetic, performs allergy testing before the procedure, or simply adjusts technique. All of this should be documented at intake, not discovered when the patient is already prepped for a biopsy.

The intake form as a clinical and financial instrument

Dermatology intake documentation serves a function that is distinct from most other medical specialties. It is simultaneously a clinical triage tool that determines the urgency and direction of the examination, a risk stratification instrument that assigns skin cancer surveillance intervals, a billing classification document that determines whether the visit is medical or cosmetic, and a liability record that demonstrates the practice asked the right questions before performing procedures on a patient taking isotretinoin or blood thinners.

A generic medical intake form handles none of these functions. It captures a medication list without flagging photosensitizers. It asks about family cancer history without distinguishing melanoma from other cancers. It has no mechanism for cosmetic-versus-medical classification. It does not ask about tanning bed use, childhood sunburns, or occupational UV exposure. The result is a practice that spends the first five minutes of every patient encounter asking questions that should have been answered on paper in the waiting room — and occasionally missing questions that should have been asked before a procedure was performed.

Practices building comprehensive patient documentation across healthcare specialties can find dermatology alongside twenty other healthcare intake form sets in the full catalog. The intake form is where the dermatology encounter begins — and when it captures the right data, every decision that follows is faster, safer, and better documented.

Dermatology intake forms — $19.99 complete set

Fillable PDF intake form + client questionnaire. Chief skin complaint, sun exposure history, medication documentation, family history, cosmetic vs medical classification, prior treatments, allergies, insurance details, and HIPAA acknowledgment. Built for dermatology practices.

View Dermatology Forms